000 | 01936 a2200517 4500 | ||
---|---|---|---|
005 | 20250517152730.0 | ||
264 | 0 | _c20180126 | |
008 | 201801s 0 0 eng d | ||
022 | _a1536-4798 | ||
024 | 7 |
_a10.1097/ICO.0000000000001182 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDavidson, Eric P | |
245 | 0 | 0 |
_aImpaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril. _h[electronic resource] |
260 |
_bCornea _cJun 2017 |
||
300 |
_a725-731 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdiponectin _xmetabolism |
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aCornea _xinnervation |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 |
_aDiabetic Neuropathies _xphysiopathology |
650 | 0 | 4 | _aDiet, High-Fat |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEnalapril _xadministration & dosage |
650 | 0 | 4 |
_aFish Oils _xadministration & dosage |
650 | 0 | 4 |
_aHypesthesia _xphysiopathology |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aStreptozocin |
650 | 0 | 4 |
_aThiobarbituric Acid Reactive Substances _xmetabolism |
650 | 0 | 4 |
_aThioctic Acid _xadministration & dosage |
650 | 0 | 4 |
_aTrigeminal Nerve Diseases _xphysiopathology |
700 | 1 | _aCoppey, Lawrence J | |
700 | 1 | _aShevalye, Hanna | |
700 | 1 | _aObrosov, Alexander | |
700 | 1 | _aKardon, Randy H | |
700 | 1 | _aYorek, Mark A | |
773 | 0 |
_tCornea _gvol. 36 _gno. 6 _gp. 725-731 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/ICO.0000000000001182 _zAvailable from publisher's website |
999 |
_c27145730 _d27145730 |